Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor.

B Seetharam, EI Christensen… - The Journal of …, 1997 - Am Soc Clin Investig
B Seetharam, EI Christensen, SK Moestrup, TG Hammond, PJ Verroust
The Journal of clinical investigation, 1997Am Soc Clin Investig
Previous studies in the rat have shown that antibodies to gp280, a protein> 200 kD and
closely associated with the early endocytic system can induce fetal malformations. Although
gp280 is thought to act as a receptor, its ligand (s) is not known. In the current study, we
report that purified gp280 from rat kidney, like the intrinsic factor-Cobalamin receptor (IFCR),
binds to the intrinsic factor-cobalamin (IFCbl) complex with an association constant of 0.3 x
10 (9) M-1 and mediates its internalization. Furthermore, antibodies raised to purified gp280 …
Previous studies in the rat have shown that antibodies to gp280, a protein > 200 kD and closely associated with the early endocytic system can induce fetal malformations. Although gp280 is thought to act as a receptor, its ligand(s) is not known. In the current study, we report that purified gp280 from rat kidney, like the intrinsic factor-Cobalamin receptor (IFCR), binds to the intrinsic factor-cobalamin (IFCbl) complex with an association constant of 0.3 x 10(9) M-1 and mediates its internalization. Furthermore, antibodies raised to purified gp280 and IFCR inhibited the binding of IF-[57Co]Cbl complex to intestinal, renal, and yolk sac apical membranes and revealed a single identically sized protein on immunoblotting of the renal membranes. Both antibodies precipitated a single radiolabeled protein > 200 kD from cellular extract from [35S]methionine-labeled yolk sac epithelial cells, and antibody to gp280 inhibited the uptake and internalization of 125IF-Cbl. Immunoelectron microscopy using the two antibodies revealed that in the kidney, both proteins were colocalized. These observations suggest that IF-Cbl complex is a ligand for gp280 and that gp280 and IFCR are identical proteins.
The Journal of Clinical Investigation